ConductScience.org, home
The Effect of Antihypertensive Drugs on Severity of Anaphylaxis and Side-effects During Venom Immunotherapy
API referenceFor AI assistants

Trial · NCT04269629

Results by group22

Each measurement the trial posted, group by group, in the words and numbers it posted.

1 to 20 of 22

Download this page as JSON
OutcomeGroupCategoryValueSpreadUnits
Frequency of Side Effects (=Systemic Reaction, SR) During Venom Immunotherapy (VIT)Patients Who Underwent VIT Updosingnumber of patients with SR with AHT treatment19Participants
Frequency of Side Effects (=Systemic Reaction, SR) During Venom Immunotherapy (VIT)Patients Who Underwent VIT Updosingnumber of patients with SR without AHT treatment74Participants
Severity of Sting ReactionsPatients With a History of an Anaphylactic Sting Reactionsevere reactions in patients with AHT treatment171Participants
Severity of Sting ReactionsPatients With a History of an Anaphylactic Sting Reactionsevere reactions in patients without AHT treatment432Participants
Correlation of the Prevalence of Cardiovascular Diseases and/or Hypertension With the Risk for More Severe Systemic Sting Reactions.Patients With Anaphylactic Sting Reactionsevere sting reaction, cardiovascular disease258Participants
Correlation of the Prevalence of Cardiovascular Diseases and/or Hypertension With the Risk for More Severe Systemic Sting Reactions.Patients With Anaphylactic Sting Reactionsevere sting reaction, no cardiovascular disease343Participants
Association of Bee Venom With a Higher Frequency of Side-effects (=Systemic Reaction, SR).Patients Who Underwent VIT UpdosingSR in patients treated with bee venom54Participants
Association of Bee Venom With a Higher Frequency of Side-effects (=Systemic Reaction, SR).Patients Who Underwent VIT UpdosingSR in patients treated with vespid venom39Participants
Correlation of High Specific Immunoglobulin E (sIgE) Levels to a Higher Frequency of Side-effects (=Systemic Reaction, SR).Patients Who Underwent VIT UpdosingSR, bee venom, IgE >0.35-3.5 kU/L17Participants
Correlation of High Specific Immunoglobulin E (sIgE) Levels to a Higher Frequency of Side-effects (=Systemic Reaction, SR).Patients Who Underwent VIT UpdosingSR, bee venom, IgE >3.5-17.5 kU/L17Participants
Correlation of High Specific Immunoglobulin E (sIgE) Levels to a Higher Frequency of Side-effects (=Systemic Reaction, SR).Patients Who Underwent VIT UpdosingSR, bee venom, IgE >17.5 kU/L8Participants
Correlation of High Specific Immunoglobulin E (sIgE) Levels to a Higher Frequency of Side-effects (=Systemic Reaction, SR).Patients Who Underwent VIT UpdosingSR, vespid venom, IgE >0.35-3.5 kU/L17Participants
Correlation of High Specific Immunoglobulin E (sIgE) Levels to a Higher Frequency of Side-effects (=Systemic Reaction, SR).Patients Who Underwent VIT UpdosingSR, vespid venom, IgE >3.5-17.5 kU/L9Participants
Correlation of High Specific Immunoglobulin E (sIgE) Levels to a Higher Frequency of Side-effects (=Systemic Reaction, SR).Patients Who Underwent VIT UpdosingSR, vespid venom, IgE >17.5 kU/L4Participants
Correlation of High Tryptase Levels to a Higher Frequency of Side-effects (=Systemic Reaction, SR).Patients Who Underwent VIT UpdosingSR in patients with tryptase <11.4µg/L74Participants
Correlation of High Tryptase Levels to a Higher Frequency of Side-effects (=Systemic Reaction, SR).Patients Who Underwent VIT UpdosingSR in patients with tryptase >11.4µg/L13Participants
Correlation of Quicker Up-dosing Protocols to a Higher Frequency of Side-effects (=Systemic Reaction, SR).Patients Who Underwent VIT UpdosingSR in patients with conventional updosing5Participants
Correlation of Quicker Up-dosing Protocols to a Higher Frequency of Side-effects (=Systemic Reaction, SR).Patients Who Underwent VIT UpdosingSR in patients with quicker updosing84Participants
Efficacy of VITPatients Who Underwent VIT for at Least 1 YearSR after sting, AHT treatment4Participants
Efficacy of VITPatients Who Underwent VIT for at Least 1 YearSR after sting, no AHT treatment15Participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04269629/results

API referenceFor AI assistants